logo

Sangamo Biosciences Inc (SGMO)



Trade SGMO now with
  Date
  Headline
2/12/2018 4:02:33 PM Sangamo Therapeutics Appoints Heather Turner As SVP And General Counsel
2/12/2018 7:40:12 AM Wedbush Is Increasing Sangamo Biosciences Inc (SGMO) FY18 Rev. Estimate To 48.1 M From 28.7 M
2/12/2018 7:39:55 AM Wedbush Is Raising Sangamo Biosciences Inc (SGMO) Q1 18 Rev. Estimate To 22.8 M From 3.4 M
2/12/2018 7:39:20 AM Wedbush Is Increasing Sangamo Biosciences Inc (SGMO) FY18 Estimate To -0.59 From -0.82
2/12/2018 7:39:03 AM Wedbush Is Increasing Sangamo Biosciences Inc (SGMO) Q1 18 Estimate To -0.01 From -0.25
2/12/2018 7:38:21 AM Wedbush Reiterates Sangamo Biosciences Inc (SGMO) At Neutral With $6 Price Target
2/6/2018 7:34:45 PM Sangamo Presents Initial Safety Data From CHAMPIONS Genome Editing Study For MPS II At WORLDSymposium
1/3/2018 7:33:16 AM Sangamo Therapeutics, Pfizer To Collaborate For Development Of Zinc Finger Protein Gene Therapy For ALS
11/15/2017 5:22:50 PM Wedbush Is Raising Sangamo Biosciences Inc (SGMO) FY18 Rev. Estimate To 28.7 M From 16.3 M
11/15/2017 5:22:35 PM Wedbush Is Increasing Sangamo Biosciences Inc (SGMO) Q4 18 Rev. Estimate To 11.1 M From 4.9 M
11/15/2017 5:22:14 PM Wedbush Is Raising Sangamo Biosciences Inc (SGMO) Q3 18 Rev. Estimate To 10.8 M From 4.6 M
11/15/2017 5:21:56 PM Wedbush Is Increasing Sangamo Biosciences Inc (SGMO) FY17 Rev. Estimate To 38.2 M From 36.4 M
11/15/2017 5:21:43 PM Wedbush Is Raising Sangamo Biosciences Inc (SGMO) Q4 17 Rev. Estimate To 14.7 M From 13.5 M
11/15/2017 5:20:30 PM Wedbush Is Raising Sangamo Biosciences Inc (SGMO) FY18 Estimate To -0.82 From -0.99